Welcoming low testosterone as a cardiovascular risk factor

被引：56

作者：

Maggio, M. ^{[2
]}

Basaria, S. ^{[1
]}

机构：

[1] Boston Univ, Androgen Clin Res Unit, Div Endocrinol & Metab, Sch Med,Boston Med Ctr,Dept Internal Med, Boston, MA 02118 USA

[2] Univ Parma, Dept Internal Med, Div Endocrinol & Metab, I-43100 Parma, Italy

来源：

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH | 2009年 / 21卷 / 04期

关键词：

hypogonadism; metabolic syndrome; diabetes; inflammation; ENDOTHELIAL PROGENITOR CELLS; ANDROGEN DEPRIVATION THERAPY; HORMONE-BINDING GLOBULIN; CORONARY-ARTERY-DISEASE; LOW SERUM TESTOSTERONE; ENDOGENOUS TESTOSTERONE; INSULIN-RESISTANCE; METABOLIC SYNDROME; BODY-COMPOSITION; SEX-HORMONES;

D O I：

10.1038/ijir.2009.25

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Male hypogonadism now has a new spectrum of complications. They are mainly cardiometabolic in nature. Low serum testosterone levels are a risk factor for diabetes, metabolic syndrome, inflammation and dyslipidemia. These metabolic and inflammatory complications are not without consequences. Recent studies have shown low serum testosterone levels to be an independent risk factor of cardiovascular and all-cause mortality. It is time to welcome low serum testosterone levels as a cardiovascular risk factor. International Journal of Impotence Research (2009) 21, 261-264; doi: 10.1038/ijir.2009.25; published online 18 June 2009

引用

页码：261 / 264

页数：4

共 34 条

[1] Hypogonadism and androgen replacement therapy in elderly men [J].

Basaria, S ;

Dobs, AS .

AMERICAN JOURNAL OF MEDICINE, 2001, 110 (07) :563-572

[2] Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy [J].

Basaria, S ;

Muller, DC ;

Carducci, MA ;

Egan, J ;

Dobs, AS .

CANCER, 2006, 106 (03) :581-588

[3] Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer [J].

Basaria, Shehzad ;

Muller, Denis C. ;

Carducci, Michael A. ;

Egan, Josephine ;

Dobs, Adrian S. .

ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (06) :612-613

[4]

Boyanov M A, 2003, Aging Male, V6, P1

[5] Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy [J].

Braga-Basaria, Milena ;

Dobs, Adrian S. ;

Muller, Denis C. ;

Carducci, Michael A. ;

John, Majnu ;

Egan, Josephine ;

Basaria, Shehzad .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3979-3983

[6] Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo [J].

Chou, TM ;

Sudhir, K ;

Hutchison, SJ ;

Ko, E ;

Amidon, TM ;

Collins, P ;

Chatterjee, K .

CIRCULATION, 1996, 94 (10) :2614-2619

[7] Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina - A randomized, double-blind, placebo-controlled study [J].

English, KM ;

Steeds, RP ;

Jones, TH ;

Diver, MJ ;

Channer, KS .

CIRCULATION, 2000, 102 (16) :1906-1911

[8] Reduced number of circulating endothelial progenitor cells in hypogonadal men [J].

Foresta, C. ;

Caretta, N. ;

Lana, A. ;

De Toni, L. ;

Biagioli, A. ;

Ferlin, A. ;

Garolla, A. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4599-4602

[9] Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway [J].

Foresta, Carlo ;

Zuccarello, Daniela ;

De Toni, Luca ;

Garolla, Andrea ;

Caretta, Nicola ;

Ferlin, Alberto .

CLINICAL ENDOCRINOLOGY, 2008, 68 (02) :284-289

[10] RELATIONSHIP OF SEX-HORMONES TO LIPIDS AND LIPOPROTEINS IN NONDIABETIC MEN [J].

HAFFNER, SM ;

MYKKANEN, L ;

VALDEZ, RA ;

KATZ, MS .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1610-1615

← 1 2 3 4 →